Baseline clinical characteristics and prognostic factors in hospitalized COVID-19 patients aged ≤ 65 years: A

Marta Betti1, Marinella Bertolotti1, Daniela Ferrante2

  • 1Infrastruttura Ricerca Formazione Innovazione, Dipartimento Attività Integrate Ricerca Innovazione, Azienda Ospedaliera "SS Antonio e Biagio e Cesare Arrigo", Alessandria, Italy.

Plos One
|March 24, 2021
PubMed

Insights

Older age, low platelet count, and high C-reactive protein (CRP) are key risk factors for severe COVID-19 in patients under 65. These prognostic factors can aid in managing coronavirus disease 2019 (COVID-19) severity.

Area of Science:

  • Infectious Diseases
  • Clinical Medicine
  • Epidemiology

Background:

  • COVID-19 exhibits varied susceptibility and clinical outcomes.
  • Prognostic factors for severe disease in younger patients (≤65 years) remain underexplored.

Purpose of the Study:

  • To identify prognostic factors associated with moderate to severe COVID-19 in hospitalized patients aged ≤65 years.

Main Methods:

  • Retrospective observational study of 171 hospitalized COVID-19 patients (March-April 2020).
  • Data collected included demographics, symptoms, comorbidities, lab results, and imaging.
  • Multivariable logistic regression analyzed factors linked to disease severity.

Main Results:

  • Age (50-65 vs 18-49), lower platelet count, and elevated C-reactive protein (CRP) were significant risk factors for severe/critical COVID-19.
  • The logistic model demonstrated good predictive capacity (C-index = 0.76).

Conclusions:

  • Patients aged ≥50 with low platelets and high CRP face increased risk of severe COVID-19.
  • These findings support enhanced clinical monitoring and management strategies for at-risk individuals.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
72
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
569
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
60
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
68
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
131